sales and profits

Pfizer, Merck Weather Weak Quarter

Wacker Chemie Tops Forecast As Polysilicon Price Steadies

DuPont Operating Profit Recedes by 16% in Q2

Dow Chemical EBITDA up 9% in Q2

LyondellBasell Boosted by U.S. Polyolefins Business in Q2

BASF Aims to Top 2013 Figures Despite Weaker H1

Linde Confirms 2013 Forecast after Strong H1

Syngenta’s H1 Earnings Dampened by Wet Spring

Andrew Witty: GSK’s China Corruption Scandal Will Hit Business

Oxea Reports Strong EBITDA Uplift in Q1 2013

Adjusted EBITDA increased from €45 million in Q1 2012 to 53 million in Q1 2013 (+18%), the third best quarterly result of Oxea since its inception in 2007.

Momentive Specialty Chemicals Announces First Quarter 2013 Results

Prices, Royalties Concerns Cloud Israel Chemicals Profit

Brenntag Reinforces Position in Challenging Macroeconomic Environment

Venezuela 2012 Oil and Fuel Exports Rise, Crude Output Slips

Gilead Profit Rises, But Sales of Older HIV Drugs Dip

Teva Pharmaceutical Banks on Thrice-weekly Copaxone

U.S. Launch of Novo's New Insulin Faces Long Delay

Strong Pet Product Sales Help Zoetis Top Estimates

Pfizer Q1 Results Fall Short

Wacker Reports Steady Start to the New Fiscal Year in Q1 2013

Clariant Posts Growth in Q1 2013

Bayer Reports Successful 2012, Q1 2013

AbbVie Delivers on Scorching Humira Drug Sales Growth

Total Profit Falls on Lower Oil Prices, Output

Eastman Announces Q1 2013 Financial Results

BASF Beats Estimates with Crop Chemicals Lift

Potash Corp Drops Bid for Israel Chemicals

Biogen Profit Beats Estimates, Raises 2013 Forecast

Dow Chemical Sees Farm Products Driving Profit This Year

U.S. Oil Production Rises for Exxon, Conoco in Q1

AstraZeneca Q1 Sales Tumble as Generic Losses Bite Deep

Lonza Business Performance on Track

Thermo Fisher Profit up as Life Tech awaits

GSK Puts Lucozade and Ribena Drink Brands up for Sale

Novartis Seeks Productivity Improvements with New CFO